74. van’t Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Bernards R, Friend SH. 2002. Expression profiling predicts outcome in breast cancer. Breast Cancer Res 5(1):57-58.

75. Virgolini I. 2000. Peptide Imaging. Diagnostic Nuclear Medicine. Berlin: Springer-Verlag. Pp. 135-158.

76. Weinstein JN, Scherf ULJ, Nishizuka SGF, Bussey AK, Kim SSL, Tanabe L, Richman S, Alexander J, Kouros-Mehr H, Maunakea A, Reinhold WC. 2002. The bioinformatics of microarray gene expression profiling. Cytometry 47:46-49.

77. Weissleder RM. 1999. Molecular imaging: exploring the next frontier. Radiology 212(3):609-614.

78. Weissleder RM. 2002. Scaling down imaging: molecular mapping of cancer in mice. Nature Rev Cancer 2:1-8.

79. Weissleder RM, Tung CH, Mahmood U, Bogdanov A Jr. 1999. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol 17(4):375-378.

80. Weissleder RM. 2001. Molecular imaging. Radiology 219:316-333.

81. West M, Blanchette C, Dressman H, Huang E, Ishida S, Spang R, Zuzan H, Olson JA Jr, Marks JR, Nevins JR. 2001. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci USA 98(20):11462-11467.

82. Yaffe MJ, Boyd NF, Byng JW, Jong RA, Fishell E, Lockwood GA, Little LE, Tritchler DL. 1998. Breast cancer risk and measured mammographic density. Eur J Cancer Prev 7(Suppl 1):S47-S55.

83. Zhao M, Beauregard DA, Loizou L, Davletov B, Brindle KM. 2001. Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nat Med 7(11):1241-1244.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement